GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Onyx Healthcare Inc (ROCO:6569) » Definitions » Research & Development

Onyx Healthcare (ROCO:6569) Research & Development : NT$118 Mil (TTM As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Onyx Healthcare Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Onyx Healthcare's Research & Development for the three months ended in Dec. 2024 was NT$32 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was NT$118 Mil.

Onyx Healthcare Research & Development Historical Data

The historical data trend for Onyx Healthcare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Onyx Healthcare Research & Development Chart

Onyx Healthcare Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.64 79.35 86.67 79.36 118.32

Onyx Healthcare Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.78 25.71 28.50 32.03 32.08

Onyx Healthcare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$118 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onyx Healthcare  (ROCO:6569) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Onyx Healthcare Research & Development Related Terms

Thank you for viewing the detailed overview of Onyx Healthcare's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Onyx Healthcare Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Onyx Healthcare Inc (ROCO:6569) » Definitions » Research & Development
Comparable Companies
ROCO:6841 ROCO:6857 ROCO:8409 VEEV GEHC ASX:PME DOCS TEM TSE:2413 HQY WAY HKSE:02587 BTSG NSE:IKS SZSE:300253 PRVA HKSE:02228 CERT NSE:SAGILITY HKSE:01833
Traded in Other Exchanges
N/A
Address
Baoqiao Road, No. 135, Lane 235, 2nd Floor, Xindian District, New Taipei, TWN, 231
Website
https://www.onyx-healthcare.com
Onyx Healthcare Inc is engaged in designing, manufacturing, and trading of medical computers and its peripherals. The company provides medical products such as AI Ready Medical PC and Tablet, Medical PC & Monitor for Digital OR (ACCEL), Telemedicine, Medical Cart Computer(Venus), Medical Power Panel PC (Mini Venus), Power Bank (UPower), Battery Management System (ORION), Mobile Medical Tablet (MD), Professional Medical All in One PC (ZEUS), etc. It operates in Taiwan , USA and Other countries and generates maximum revenue from Tsaiwan.

Onyx Healthcare Headlines

No Headlines